These results support an essential role for Cdc37 in concert with Hsp90 in maintaining oncogenic protein kinase clients and endorse the therapeutic potential of targeting Cdc37/Hsp90 in cancer [32]. This evidence concerns the gene HSP90AB1 and cancer.